Thursday, May 19, 2022 9:59:58 AM
This is extremely disheartening to me. "He did say that the talk, journal article and ASCO were on separate parallel tracks and not necessarily related. The article could come out tomorrow or in weeks, it is not tied to ASCO (my interpretation, ASCO may not be the big moment we are waiting for). Once the journal is out they will be free to talk a lot more. For now they are in damage control mode including getting the fake articles taken down (check) and even corrected."
Separate parallel tracks? That was never discussed or PR'd by company.
-TLD/Journal, that's all we have been told. Quiet period based on getting across THAT finish line.
-After 19 months of silence, they let someone partially reveal the data and that doesn't end the quiet period?
-After years of talking about the naked shorts and cabal, they don't see a massive smash down coming by doing that?
-And, apparently still in a quiet period with no Journal or TLD PR in sight? So, essentially they have not been able to defend themselves?
Awful and potentially open to liability based on fiduciary responsibilities, IMO.
Separate parallel tracks? That was never discussed or PR'd by company.
-TLD/Journal, that's all we have been told. Quiet period based on getting across THAT finish line.
-After 19 months of silence, they let someone partially reveal the data and that doesn't end the quiet period?
-After years of talking about the naked shorts and cabal, they don't see a massive smash down coming by doing that?
-And, apparently still in a quiet period with no Journal or TLD PR in sight? So, essentially they have not been able to defend themselves?
Awful and potentially open to liability based on fiduciary responsibilities, IMO.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
